Advertisement
Screener

CRONOS GROUP INC. (CRON) Payments to Acquire Equity Method Investments

2.8 / 5 stars · 68/120 Roast Me

CRONOS GROUP INC. Payments to Acquire Equity Method Investments

CRONOS GROUP INC. (CRON) reported Payments to Acquire Equity Method Investments of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-29.

Discontinued › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquireEquityMethodInvestments · last filed 2024-02-29

  • CRONOS GROUP INC. payments to acquire equity method investments for the quarter ending 2020-12-31 was $0.00.
  • CRONOS GROUP INC. payments to acquire equity method investments for the quarter ending 2020-09-30 was $0.00.
  • CRONOS GROUP INC. payments to acquire equity method investments for the quarter ending 2020-06-30 was $0.00.
  • CRONOS GROUP INC. payments to acquire equity method investments for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
  • CRONOS GROUP INC. payments to acquire equity method investments for fiscal 2023 was $0.00.
  • CRONOS GROUP INC. payments to acquire equity method investments for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
  • CRONOS GROUP INC. payments to acquire equity method investments for fiscal 2021 was $110.39M.
  • CRONOS GROUP INC. payments to acquire equity method investments for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
Period endPayments to Acquire Equity Method Investments 3 monthPayments to Acquire Equity Method Investments 6 monthPayments to Acquire Equity Method Investments 9 monthPayments to Acquire Equity Method Investments 12 month
2023-12-31$0.00
10-K · filed 2024-02-29
2022-12-31$0.00
10-K · filed 2024-02-29
2021-12-31$110.39M
10-K · filed 2024-02-29
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$0.00
derived: sum of 2 quarters · filed 2023-02-28
$0.00
derived: sum of 3 quarters · filed 2023-02-28
$0.00
10-K · filed 2023-02-28
2020-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$0.00
derived: sum of 2 quarters · filed 2020-11-05
$0.00
10-Q · filed 2020-11-05
$0.00
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
$0.00
10-Q · filed 2020-08-06
$0.00
derived: sum of 3 quarters · filed 2022-03-01
$0.00
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31$0.00
10-Q · filed 2020-05-08
$0.00
derived: sum of 2 quarters · filed 2022-03-01
$0.00
derived: sum of 3 quarters · filed 2022-03-01
$0.00
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$0.00
derived: sum of 2 quarters · filed 2022-03-01
$0.00
derived: sum of 3 quarters · filed 2022-03-01
$1.66M
10-K · filed 2022-03-01
2019-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$0.00
derived: sum of 2 quarters · filed 2020-11-05
$1.66M
10-Q · filed 2020-11-05
2019-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
$1.66M
10-Q · filed 2020-08-06
2019-03-31$1.66M
10-Q · filed 2020-05-08
2018-12-31$480.00K
10-K · filed 2021-02-26
2017-12-31$830.00K
10-K/A · filed 2020-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87